Last reviewed · How we verify
Vaxigrip vaccine
At a glance
| Generic name | Vaxigrip vaccine |
|---|---|
| Sponsor | Mahidol University |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Effect of infLuenza vaccInation After Myocardial INfArction on Cardiac inflammaTory responsE (PHASE4)
- Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women (PHASE3)
- Efficacy Safety Study of Flu Vaccine in Immunodepression Patients (PHASE3)
- INfluenza VaccInation To Mitigate typE 1 Diabetes (PHASE4)
- Does Repeat Influenza Vaccination Constrain Influenza Immune Responses and Protection
- Maternal Determinants of Immunity to Influenza (PHASE4)
- Safety and Immunogenicity of GPO Seasonal Tetravalent Inactivated Split Virion Influenza Vaccine in Healthy Thais (PHASE1, PHASE2)
- Seasonal Influenza Vaccine Effectiveness Study in Kenya
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Vaxigrip vaccine CI brief — competitive landscape report
- Vaxigrip vaccine updates RSS · CI watch RSS
- Mahidol University portfolio CI